Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Research
  • DPHARM: How to address the clinical trial enrollment crisis?

DPHARM: How to address the clinical trial enrollment crisis?

September 17, 2026Posted inResearch

Clinical trials are facing an enrollment crisis. Around 80% of trials don’t meet their enrollment timelines, and fewer than 5% of eligible adult cancer patients participate in trials.

Post navigation

Previous Post
After one failed acquisition attempt, Lisata finds lifeline in Marea merger
Next Post
Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol

Recent Posts

  • Sentira Brings Claude’s AI to 10x Genomics’ Chromium Platform
  • FDA Delays PDUFA Action on Agios’ Mitapivat sNDA for SCD
  • StockWatch: Gene Editing Shares Jump on ESGCT Data, FDA Draft Guidance
  • Opentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure
  • 100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top